Editorials |
From the Carolina Cardiovascular Biology Center (S.-W.J., C.P.), Departments of Cell and Molecular Physiology (S.-W.J.) and Medicine (C.P.), the Curriculum in Genetics and Molecular Biology (S.-W.J.), School of Medicine, University of North Carolina at Chapel Hill.
Correspondence to Cam Patterson, MD, Director, Division of Cardiology and Carolina Cardiovascular Biology Center, University of North Carolina at Chapel Hill, 8200 Medical Biomolecular Research Building, Chapel Hill, NC 27599-7126; E-mail cpatters@med.unc.edu
See related article, pages 12–15
Key Words: arterial specification Sox protein zebrafish
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Vertebrates have evolved 2 types of blood vessels—arteries and veins—that function to supply oxygen and nutrients and remove cellular waste. To efficiently accomplish these specialized functions, arteries and veins have developed distinct morphological and molecular differences. As a result, the endothelial cells that compose arteries and veins are vastly different in their biochemical and cellular properties. During development, the nascent endothelial cells generated from hemangioblasts or angioblasts1,2 undergo tightly regulated specification and differentiation processes to adopt either the arterial or venous endothelial fate. Differentiated endothelial cells migrate and aggregate to form either arteries or veins according to their adopted fate.3 Dysregulation of these regulated events often results in devastating consequences. For instance, failure to segregate arterial and venous endothelial cells causes potentially fatal clinical conditions such as arteriovenous malformation, hereditary hemorrhagic telangiectasia, and cerebral cavernous malformation.4
Significant progress has been made in understanding how nascent endothelial cells adopt the arterial fate, resulting in identification of several key signaling molecules and their intracellular transducers involved in the specification of arterial endothelial cells.5 However, transcription factors that function downstream of these signaling cascades are largely unknown to date. Recently, hey2/Gridlock,6,7 a member of the hairy and enhancer of split-related family of bHLH transcription factors, and Foxc1 and Foxc2,8,9 which are forkhead transcription factors, have been implicated in arterial specification (Figure). A report in this issue of Circulation Research by Herpers et al elucidates the essential function of another transcription factor family, Sox, in this process.10
| |||||||||||
Related Article:
Circ. Res. 2008 102: 12-15.
This article has been cited by other articles:
![]() |
A. T. Yetman and T. Graham The dilated aorta in patients with congenital cardiac defects. J. Am. Coll. Cardiol., February 10, 2009; 53(6): 461 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aitsebaomo, A. L. Portbury, J. C. Schisler, and C. Patterson Brothers and Sisters: Molecular Insights Into Arterial-Venous Heterogeneity Circ. Res., October 24, 2008; 103(9): 929 - 939. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |